ALEO2 Fundamental Analysis - EO2

Fundamental Rating

Overall ALEO2 gets a fundamental rating of 2 out of 10. We evaluated ALEO2 against 75 industry peers in the Oil, Gas & Consumable Fuels industry. While ALEO2 seems to be doing ok healthwise, there are quite some concerns on its profitability. ALEO2 does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

1.1 Basic Checks

ALEO2 had negative earnings in the past year.
In the past year ALEO2 had a positive cash flow from operations.
ALEO2 had positive earnings in 4 of the past 5 years.
ALEO2 had a positive operating cash flow in 4 of the past 5 years.

1.2 Ratios

The Return On Assets of ALEO2 (-0.23%) is worse than 74.67% of its industry peers.
With a Return On Equity value of -0.45%, ALEO2 is not doing good in the industry: 74.67% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
ROA	-0.22%
ROE	-0.45%
ROIC	N/A

ROA(3y)3.7%

ROA(5y)2.69%

ROE(3y)8.38%

ROE(5y)6.12%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 55.94%, ALEO2 is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
ALEO2's Gross Margin has improved in the last couple of years.
ALEO2 does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	55.94%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-3.8%

GM growth 5Y19.22%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

ALEO2 does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ALEO2 remains at a similar level compared to 1 year ago.
ALEO2 has less shares outstanding than it did 5 years ago.
The debt/assets ratio for ALEO2 has been reduced compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of 1.56, we must say that ALEO2 is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.56, ALEO2 is in line with its industry, outperforming 41.33% of the companies in the same industry.
ALEO2 has a Debt/Equity ratio of 0.36. This is a healthy value indicating a solid balance between debt and equity.
ALEO2's Debt to Equity ratio of 0.36 is fine compared to the rest of the industry. ALEO2 outperforms 62.67% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.36
Debt/FCF	N/A
Altman-Z	1.56

ROIC/WACCN/A

WACC5.91%

2.3 Liquidity

ALEO2 has a Current Ratio of 2.14. This indicates that ALEO2 is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 2.14, ALEO2 belongs to the best of the industry, outperforming 84.00% of the companies in the same industry.
A Quick Ratio of 1.46 indicates that ALEO2 should not have too much problems paying its short term obligations.
ALEO2 has a better Quick ratio (1.46) than 77.33% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	2.14
Quick Ratio	1.46

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for ALEO2 have decreased strongly by -642.86% in the last year.
ALEO2 shows a decrease in Revenue. In the last year, the revenue decreased by -0.28%.
Measured over the past years, ALEO2 shows a small growth in Revenue. The Revenue has been growing by 4.28% on average per year.

EPS 1Y (TTM)-642.86%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-187.5%

Revenue 1Y (TTM)-0.28%

Revenue growth 3Y-0.53%

Revenue growth 5Y4.28%

Sales Q2Q%1.5%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALEO2. In the last year negative earnings were reported.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ALEO2 is on the same level as its industry peers.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	7.08

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for ALEO2!.

		Industry Rank	Sector Rank
Dividend Yield	0%

More info and screens

Find the best dividend stocks

Show peers with best dividend

EO2

EPA:ALEO2 (1/16/2026, 7:00:00 PM)

2.78

0 (0%)

Chartmill FA Rating

GICS SectorEnergy

GICS IndustryGroupEnergy

GICS IndustryOil, Gas & Consumable Fuels

Earnings (Last)N/A N/A

Earnings (Next)N/A N/A

Inst OwnersN/A

Inst Owner ChangeN/A

Ins Owners28.33%

Ins Owner ChangeN/A

Market Cap6.67M

Revenue(TTM)30.41M

Net Income(TTM)-90.00K

AnalystsN/A

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	0%

Yearly DividendN/A

Dividend Growth(5Y)N/A

DP0%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.22
P/FCF	N/A
P/OCF	3.61
P/B	0.32
P/tB	0.34
EV/EBITDA	7.08

EPS(TTM)-0.38

EYN/A

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)-0.38

FCFYN/A

OCF(TTM)0.77

OCFY27.73%

SpS12.57

BVpS8.75

TBVpS8.07

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-0.22%
ROE	-0.45%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	55.94%
FCFM	N/A

ROA(3y)3.7%

ROA(5y)2.69%

ROE(3y)8.38%

ROE(5y)6.12%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-3.8%

GM growth 5Y19.22%

F-Score5

Asset Turnover0.75

Health

		Industry Rank	Sector Rank
Debt/Equity	0.36
Debt/FCF	N/A
Debt/EBITDA	3.68
Cap/Depr	79.14%
Cap/Sales	9.19%
Interest Coverage	N/A
Cash Conversion	93.43%
Profit Quality	N/A
Current Ratio	2.14
Quick Ratio	1.46
Altman-Z	1.56

F-Score5

WACC5.91%

ROIC/WACCN/A

Cap/Depr(3y)115.4%

Cap/Depr(5y)96.64%

Cap/Sales(3y)8.27%

Cap/Sales(5y)6.82%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-642.86%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-187.5%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-0.28%

Revenue growth 3Y-0.53%

Revenue growth 5Y4.28%

Sales Q2Q%1.5%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-480%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y86.42%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y169.92%

OCF growth 3Y-29.17%

OCF growth 5Y-11.33%

EO2 / ALEO2.PA FAQ

What is the ChartMill fundamental rating of EO2 (ALEO2.PA) stock?

ChartMill assigns a fundamental rating of 2 / 10 to ALEO2.PA.

Can you provide the valuation status for EO2?

ChartMill assigns a valuation rating of 0 / 10 to EO2 (ALEO2.PA). This can be considered as Overvalued.

Can you provide the profitability details for EO2?

EO2 (ALEO2.PA) has a profitability rating of 2 / 10.

What is the financial health of EO2 (ALEO2.PA) stock?

The financial health rating of EO2 (ALEO2.PA) is 5 / 10.

EO2 (ALEO2.PA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

EO2 / ALEO2.PA FAQ

What is the ChartMill fundamental rating of EO2 (ALEO2.PA) stock?

Can you provide the valuation status for EO2?

Can you provide the profitability details for EO2?

What is the financial health of EO2 (ALEO2.PA) stock?